CRIS Current Research Information System

MANZOLI, LUCIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 9.433
NA - Nord America 9.416
EU - Europa 7.872
AF - Africa 768
SA - Sud America 538
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 3
Totale 28.054
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.276
SG - Singapore 2.691
IT - Italia 2.360
CN - Cina 2.354
VN - Vietnam 2.310
GB - Regno Unito 1.271
DE - Germania 993
SE - Svezia 920
HK - Hong Kong 596
FR - Francia 407
BR - Brasile 375
IN - India 371
RU - Federazione Russa 324
KR - Corea 309
NL - Olanda 309
JP - Giappone 220
UA - Ucraina 208
IE - Irlanda 207
TG - Togo 194
FI - Finlandia 190
SC - Seychelles 161
CI - Costa d'Avorio 140
ZA - Sudafrica 140
AT - Austria 105
CH - Svizzera 93
CA - Canada 92
EE - Estonia 88
BG - Bulgaria 87
HR - Croazia 86
AR - Argentina 77
JO - Giordania 68
NG - Nigeria 68
ID - Indonesia 62
PH - Filippine 62
BE - Belgio 60
TH - Thailandia 58
BD - Bangladesh 47
TR - Turchia 45
PL - Polonia 38
PK - Pakistan 36
ES - Italia 32
IQ - Iraq 30
TW - Taiwan 28
MX - Messico 24
EC - Ecuador 22
RO - Romania 22
UZ - Uzbekistan 22
IR - Iran 21
SA - Arabia Saudita 21
CO - Colombia 19
AU - Australia 16
LT - Lituania 15
GR - Grecia 14
IL - Israele 12
TN - Tunisia 12
EG - Egitto 11
MA - Marocco 11
MY - Malesia 11
VE - Venezuela 11
LB - Libano 10
UY - Uruguay 10
AE - Emirati Arabi Uniti 8
CL - Cile 8
PY - Paraguay 8
KE - Kenya 7
CZ - Repubblica Ceca 6
JM - Giamaica 6
KZ - Kazakistan 6
NZ - Nuova Zelanda 6
PT - Portogallo 6
ET - Etiopia 5
LV - Lettonia 5
OM - Oman 5
PE - Perù 5
AZ - Azerbaigian 4
BZ - Belize 4
DK - Danimarca 4
HU - Ungheria 4
NP - Nepal 4
SN - Senegal 4
AM - Armenia 3
DZ - Algeria 3
GH - Ghana 3
MD - Moldavia 3
PS - Palestinian Territory 3
QA - Qatar 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
AL - Albania 2
BO - Bolivia 2
CR - Costa Rica 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GE - Georgia 2
HN - Honduras 2
KG - Kirghizistan 2
KW - Kuwait 2
PA - Panama 2
SS - ???statistics.table.value.countryCode.SS??? 2
Totale 28.026
Salva come PNG Salva come JPEG
Città #
Singapore 1.896
Ashburn 1.057
Southend 1.019
Chandler 806
Bologna 794
Fairfield 712
Hong Kong 557
Ho Chi Minh City 536
Santa Clara 531
Hefei 511
Hanoi 482
San Jose 418
Ann Arbor 415
Houston 408
Woodbridge 317
Wilmington 290
Dallas 289
Beijing 277
Princeton 267
Seattle 258
Dong Ket 251
Boardman 241
Cambridge 229
Dublin 206
Seoul 202
Lomé 194
Milan 172
Frankfurt am Main 156
Tokyo 151
Lauterbourg 150
Abidjan 140
Helsinki 127
Los Angeles 127
New York 121
Nanjing 118
Padova 115
Westminster 108
Jacksonville 106
Council Bluffs 93
Berlin 91
Da Nang 87
Sofia 87
Buffalo 82
Vienna 79
Haiphong 72
Munich 70
Bern 69
Amman 66
Turin 66
Jinan 65
Abeokuta 64
San Diego 64
Redondo Beach 58
Redwood City 56
Brussels 55
Saint Petersburg 55
Rome 54
Johannesburg 52
Florence 50
Guangzhou 48
Changsha 47
Redmond 46
Medford 44
London 43
Shenyang 43
Bengaluru 42
Chicago 41
Shanghai 41
Amsterdam 40
São Paulo 40
Moscow 39
Orem 39
Udine 38
Bremen 37
The Dalles 36
Jakarta 34
Toronto 34
Turku 33
Nanchang 32
Montreal 31
Lappeenranta 30
Parma 29
Castel Maggiore 28
Falkenstein 28
Nuremberg 28
Des Moines 27
Hebei 27
Bangkok 26
Tianjin 26
Falls Church 25
Hải Dương 25
Modena 25
Biên Hòa 24
Verona 24
Warsaw 24
Can Tho 22
Dearborn 22
San Francisco 22
Tappahannock 22
Zhengzhou 21
Totale 17.522
Salva come PNG Salva come JPEG
Nome #
Multiple roles of phosphoinositide-specific phospholipase C isozymes. 396
AEducaAR, Anatomical Education in Augmented Reality: A Pilot Experience of an Innovative Educational Tool Combining AR Technology and 3D Printing 357
Cell signaling pathways in autosomal-dominant leukodystrophy (ADLD): the intriguing role of the astrocytes 341
Ankrd2/ARPP is a novel Akt2 specific substrate and regulates myogenic differentiation upon cellular exposure to H(2)O(2 288
Clinical and molecular insights in erythropoiesis regulation of signal transduction pathways in myelodysplastic syndromes and β-thalassemia 281
Near-peer teaching in human anatomy from a tutors’ perspective: An eighteen-year-old experience at the university of Bologna 274
Activation of nuclear inositide signalling pathways during erythropoietin therapy in low-risk MDS patients 272
Three-dimensional virtual anatomy as a new approach for medical student’s learning 262
A miRNA screening identifies miR-192-5p as associated with response to azacitidine and lenalidomide therapy in myelodysplastic syndromes 256
Combining prelamin A accumulation and oxidative stress: A strategy to target glioblastoma 252
Prolonged low-dose azacitidine schedule in high-risk MDS patients: Hematologic and molecular response 252
Impact of phospholipase C β1 in glioblastoma: a study on the main mechanisms of tumor aggressiveness 249
Inositide-Dependent Nuclear Signalling in Health and Disease 245
Endoscopic endonasal anatomy of the ophthalmic artery in the optic canal 244
Anatomic Cartography of the Hypogastric Nerves and Surgical Insights for Autonomic Preservation during Radical Pelvic Procedures. 244
In vitro reparative dentin: a biochemical and morphological study. 240
Anatomy of the optic canal and its clinical role 233
Body donor reperfusion and re-ventilation in medical training: an Italian study testing SimLife® 231
Molecular Characterization of High-Risk MDS Patients Treated with Azacitidine and Lenalidomide: Role of Inositide-Dependent Signalling, Mutations and Microrna 226
Response of high-risk MDS to azacitidine and lenalidomide is impacted by baseline and acquired mutations in a cluster of three inositide-specific genes 224
AZACITIDINE IN MYELODYSPLASTIC SYNDROMES: RETROSPECTIVE EVALUATION OF LONG-RESPONDER PATIENTS 222
Augmented Reality-Assisted Periosteum Pedicled Flap Harvesting for Head and Neck Reconstruction: An Anatomical and Clinical Viability Study of a Galeo-Pericranial Flap 222
Clonal activation of Akt in low-risk MDS patients with del(5q) treated with lenalidomide 219
Nuclear Inositides and Inositide-Dependent Signaling Pathways in Myelodysplastic Syndromes 219
Anatomical Laser Microdissection of the Ileum Reveals mtDNA Depletion Recovery in A Mitochondrial Neuro-Gastrointestinal Encephalomyopathy (MNGIE) Patient Receiving Liver Transplant 218
Catalytic activity of nuclear PLC-beta(1) is required for its signalling function during C2C12 differentiation. 218
Strategic Role of Nuclear Inositide Signalling in Myelodysplastic Syndromes Therapy 217
AZACITIDINE IN HIGH AND LOW RISK MYELODYSPLASTIC SYNDROMES: RETROSPECTIVE EVALUATION OF 57 PATIENTS TREATED WITH 4 DIFFERENT THERAPEUTIC REGIMENS 215
A scientific (c)old case at “Luigi Cattaneo” Anatomical Wax Collection in Bologna: solving an intriguing puzzle? 215
AZACITIDINE FOR HIGH RISK MYELODYSPLASTIC SYNDROMES. RETROSPECTIVE EVALUATION OF TWO DIFFERENT DOSING SCHEDULES 213
PLC-β1 and cell differentiation: An insight into myogenesis and osteogenesis 207
Nuclear inositide signaling and cell cycle 207
Role of PLCγ1 in the modulation of cell migration and cell invasion in glioblastoma 206
An increased expression of PI-PLCβ1 is associated with myeloid differentiation and a longer response to azacitidine in myelodysplastic syndromes 205
Prospective phase II Study on 5-days azacitidine for treatment of symptomatic and/or erythropoietin unresponsive patients with low/INT-1-risk myelodysplastic syndromes 203
Nuclear phospholipase C isoenzyme imbalance leads to pathologies in brain, hematologic, neuromuscular, and fertility disorders 203
Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia 202
Nuclear Inositide Signaling via Phospholipase C 201
Modulating Phosphoinositide Profiles as a Roadmap for Treatment in Acute Myeloid Leukemia 201
Early Increase of Phospholipase Cbeta1 (PI-PLCbeta1) Gene Expression Predicts Azacitidine Responsiveness in MDS Patients 200
Endoscopic endonasal approach to primitive Meckel's cave tumors: a clinical series 200
Phospholipases in Gliomas: Current Knowledge and Future Perspectives from Bench to Bedside 198
Lamin B1 accumulation’s effects on autosomal dominant leukodystrophy (ADLD): Induction of reactivity in the astrocytes 197
DIFFERENTIAL EFFECT OF LENALIDOMIDE ON INDUCTION OF INOSITIDE-DEPENDENT ERYTHROPOIESIS AND CELL CYCLE IN MYELODYSPLASTIC SYNDROMES 196
Nuclear Localization of Diacylglycerol Kinase Alpha in K562 Cells Is Involved in Cell Cycle Progression 196
Location-dependent role of phospholipase C signaling in the brain: Physiology and pathology 195
The wide and growing range of lamin B‑related diseases: from laminopathies to cancer 194
Intranuclear 3'-phosphoinositide metabolism and Akt signaling: New mechanisms for tumorigenesis and protection against apoptosis? 192
Dissecting human anatomy learning process through anatomical education with augmented reality: AEducAR 2.0, an updated interdisciplinary study 189
Nuclear inositides: facts and perspectives. 189
To the Heart of IFs Function: Do they Aggregate on Purpose? 188
Epigenetic regulation of nuclear inositide signalling in high-risk MDS patients 186
IPMK and β-catenin mediate PLC-β1-dependent signaling in myogenic differentiation 186
Anatomical variations of the right renal and spermatic arteries: a case report 185
PLA-Based Mineral-Doped Scaffolds Seeded with Human Periapical Cyst-Derived MSCs: A Promising Tool for Regenerative Healing in Dentistry 185
The whole body donation program at the university of Bologna: A report based on the experience of one of the oldest university in Western world 185
Inositide signaling: Nuclear targets and involvement in myelodysplastic syndromes 184
Nuclear diacylglycerol kinase-theta is activated in response to nerve growth factor stimulations of PC12 cells 183
Inositide signaling in the nucleus: From physiology to pathology. 183
Phosphoinositide-dependent signaling in cancer: A focus on phospholipase C isozymes 183
Regulation of nuclear phospholipase C activity 182
Phospholipase C beta1 (PI-PLCbeta1)/Cyclin D3/protein kinase C (PKC) alpha signaling modulation during iron-induced oxidative stress in myelodysplastic syndromes (MDS) 182
Subcellular localization relevance and cancer-associated mechanisms of diacylglycerol kinases 181
Emerging Roles of Phospholipase C Beta Isozymes as Potential Biomarkers in Cardiac Disorders 180
Investigation of human cadavers: one year of anatomic variants and their clinical correlation 179
Real-time PCR as a tool for quantitative analysis of PI-PLCbeta1 gene expression in myelodysplastic syndrome. 178
Inositide-specific phospholipase c beta1 gene deletion in the progression of myelodysplastic syndrome to acute myeloid leukemia 176
Unilateral absence of Casserio’s nerve and a communicating branch to the median nerve. An additional variant of brachial flexors motor innervation 176
Phospholipase C-β1 interacts with cyclin E in adipose- derived stem cells osteogenic differentiation 176
Advances in MDS/AML and inositide signalling 174
Structural Variants at the LMNB1 Locus: Deciphering Pathomechanisms in Autosomal Dominant Adult-Onset Demyelinating Leukodystrophy 173
Inositide-dependent signaling pathways as new therapeutic targets in myelodysplastic syndromes 173
Nuclear phospholipase C beta1 and cellular differentiation. 172
Effect of Lenalidomide Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients 172
The anatomy of the pelvic plexus in female cadavers: implications for retroperitoneal nerve-sparing surgery 171
Expression of phospholipase C beta family isoenzymes in C2C12 myoblasts during terminal differentiation. 170
Signaling pathways and bone marrow microenvironment in myelodysplastic neoplasms 169
Lamin B1 as a key modulator of the developing and aging brain 168
Augmented Reality in Higher Education an Exploratory Study on the Beliefs of Medical Students 168
Signaling Role of Pericytes in Vascular Health and Tissue Homeostasis 165
Hepato-gastric and spleno-mesenteric arterial trunks: anatomical variation report and review of literature 165
Phosphoinositide 3-kinase/Akt involvement in arsenic trioxide resistance of human leukemia cells 165
The involvement of signaling pathways in the pathogenesis of osteoarthritis: An update 164
Exploring the controversial role of PI3K signalling in CD4+ regulatory T (T-Reg) cells 163
Nuclear Phosphoinositides as Key Determinants of Nuclear Functions 161
Targeting the liver kinase B1/AMP-activated protein kinase pathway as a therapeutic strategy for hematological malignancies 161
Nuclear Nox4-Derived Reactive Oxygen Species in Myelodysplastic Syndromes 161
PLC and PI3K/Akt/mTOR signalling in disease and cancer 160
CLONAL ACTIVATION OF AKT IN LOW-RISK MDS PATIENTS WITH DEL(5Q) TREATED WITH LENALIDOMIDE 160
PI-PLCβ1b affects Akt activation, cyclin E expression, and caspase cleavage, promoting cell survival in pro-B-lymphoblastic cells exposed to oxidative stress 160
Effect of azacitidine on inositide-dependent signalling pathways in low-risk MDS patients 159
Hypo and retrotympanum: the importance of anatomical variants 159
Epigenetic regulation of nuclear PLCbeta1 and Cyclin D3 during Azacitidine treatment 159
Phosphoinositide 3 Kinase signaling in human stem cells from reprogramming to differentiation: A tale in cytoplasmic and nuclear compartments 159
Role of inositide signalling regulation in higher-risk MDS patients during epigenetic therapy 157
Epigenetic Regulation of Lipid Signalling Pathways In Low-Risk MDS Patients During Azacitidine Treatment 156
Modulation of nuclear PI-PLCbeta1 during cell differentiation 155
Significance of subnuclear licalization of key players of inositol lipid cycle. 154
Metabolism and signaling activities of nuclear lipids 154
Glycogen Synthase Kinase-3 and phospholipase C-beta signalling: Roles and possible interactions in myelodysplastic syndromes and acute myeloid leukemia 154
Totale 20.045
Salva come PNG Salva come JPEG
Categoria #
all - tutte 74.501
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.501
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021747 0 0 0 0 0 0 0 0 0 97 98 552
2021/20223.050 221 56 175 284 241 144 133 187 106 503 530 470
2022/20233.544 341 450 178 523 303 266 223 220 536 62 212 230
2023/20241.464 96 197 139 145 152 207 68 81 100 131 64 84
2024/20254.617 167 527 363 299 672 253 406 203 136 369 323 899
2025/202610.172 922 1.235 1.091 774 1.190 633 1.208 343 2.029 747 0 0
Totale 28.715